These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 30177378)

  • 1. Design and synthesis of cyclopropane-based conformationally restricted GABA analogues as selective inhibitors for betaine/GABA transporter 1.
    Suemasa A; Watanabe M; Kobayashi T; Suzuki H; Fukuda H; Minami M; Shuto S
    Bioorg Med Chem Lett; 2018 Nov; 28(20):3395-3399. PubMed ID: 30177378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclopropane-based conformational restriction of GABA by a stereochemical diversity-oriented strategy: identification of an efficient lead for potent inhibitors of GABA transports.
    Nakada K; Yoshikawa M; Ide S; Suemasa A; Kawamura S; Kobayashi T; Masuda E; Ito Y; Hayakawa W; Katayama T; Yamada S; Arisawa M; Minami M; Shuto S
    Bioorg Med Chem; 2013 Sep; 21(17):4938-50. PubMed ID: 23886812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereochemical diversity-oriented conformational restriction strategy. Development of potent histamine H3 and/or H4 receptor antagonists with an imidazolylcyclopropane structure.
    Watanabe M; Kazuta Y; Hayashi H; Yamada S; Matsuda A; Shuto S
    J Med Chem; 2006 Sep; 49(18):5587-96. PubMed ID: 16942032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of γ-Aminobutyric Acid (GABA) Analogues Conformationally Restricted by Bicyclo[3.1.0]hexane/hexene or [4.1.0]Heptane/heptene Backbones as Potent Betaine/GABA Transporter Inhibitors.
    Mitsui K; Lie MEK; Saito N; Fujiwara K; Watanabe M; Wellendorph P; Shuto S
    Org Lett; 2022 Jun; 24(23):4151-4154. PubMed ID: 35674784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of the First Highly Subtype-Selective Inhibitor of Human GABA Transporter GAT3.
    Damgaard M; Al-Khawaja A; Vogensen SB; Jurik A; Sijm M; Lie ME; Bæk MI; Rosenthal E; Jensen AA; Ecker GF; Frølund B; Wellendorph P; Clausen RP
    ACS Chem Neurosci; 2015 Sep; 6(9):1591-9. PubMed ID: 26154082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclopropane-based conformational restriction of histamine. (1S,2S)-2-(2-aminoethyl)-1-(1H-imidazol-4-yl)cyclopropane, a highly selective agonist for the histamine H3 receptor, having a cis-cyclopropane structure.
    Kazuta Y; Hirano K; Natsume K; Yamada S; Kimura R; Matsumoto S; Furuichi K; Matsuda A; Shuto S
    J Med Chem; 2003 May; 46(10):1980-8. PubMed ID: 12723960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of the bioactive conformation of histamine H3 receptor antagonists by the cyclopropylic strain-based conformational restriction strategy.
    Watanabe M; Hirokawa T; Kobayashi T; Yoshida A; Ito Y; Yamada S; Orimoto N; Yamasaki Y; Arisawa M; Shuto S
    J Med Chem; 2010 May; 53(9):3585-93. PubMed ID: 20397706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of versatile cis- and trans-dicarbon-substituted chiral cyclopropane units: synthesis of (1S,2R)- and (1R,2R)-2-aminomethyl-1-(1H-imidazol-4-yl)cyclopropanes and their enantiomers as conformationally restricted analogues of histamine.
    Kazuta Y; Matsuda A; Shuto S
    J Org Chem; 2002 Mar; 67(5):1669-77. PubMed ID: 11871901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological evaluation of new derivatives of 2-substituted 4-hydroxybutanamides as GABA uptake inhibitors.
    Kulig K; Więckowski K; Więckowska A; Gajda J; Pochwat B; Höfner GC; Wanner KT; Malawska B
    Eur J Med Chem; 2011 Jan; 46(1):183-90. PubMed ID: 21111516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological Characterization of a Betaine/GABA Transporter 1 (BGT1) Inhibitor Displaying an Unusual Biphasic Inhibition Profile and Anti-seizure Effects.
    Lie MEK; Kickinger S; Skovgaard-Petersen J; Ecker GF; Clausen RP; Schousboe A; White HS; Wellendorph P
    Neurochem Res; 2020 Jul; 45(7):1551-1565. PubMed ID: 32248400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological Characterization of [
    Al-Khawaja A; Haugaard AS; Marek A; Löffler R; Thiesen L; Santiveri M; Damgaard M; Bundgaard C; Frølund B; Wellendorph P
    ACS Chem Neurosci; 2018 Mar; 9(3):545-554. PubMed ID: 29131576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First photoswitchable neurotransmitter transporter inhibitor: light-induced control of γ-aminobutyric acid transporter 1 (GAT1) activity in mouse brain.
    Quandt G; Höfner G; Pabel J; Dine J; Eder M; Wanner KT
    J Med Chem; 2014 Aug; 57(15):6809-21. PubMed ID: 25025595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Syntheses and evaluation of fluorinated conformationally restricted analogues of GABA as potential inhibitors of GABA aminotransferase.
    Wang Z; Silverman RB
    Bioorg Med Chem; 2006 Apr; 14(7):2242-52. PubMed ID: 16314106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of imidazole alkanoic acids as mGAT3 selective GABA uptake inhibitors.
    Hack S; Wörlein B; Höfner G; Pabel J; Wanner KT
    Eur J Med Chem; 2011 May; 46(5):1483-98. PubMed ID: 21353350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological identification of a guanidine-containing β-alanine analogue with low micromolar potency and selectivity for the betaine/GABA transporter 1 (BGT1).
    Al-Khawaja A; Petersen JG; Damgaard M; Jensen MH; Vogensen SB; Lie ME; Kragholm B; Bräuner-Osborne H; Clausen RP; Frølund B; Wellendorph P
    Neurochem Res; 2014 Oct; 39(10):1988-96. PubMed ID: 24852577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The activity of cis and trans -2- (aminomethyl) cyclopropane carboxylic acids on GABA - related mechanisms in the central nervous system of Limulus and Periplanata and of mammals.
    Gardner CR; Roberts CJ; Walker RJ; Chidley L; Clements-Jewery S
    Neuropharmacology; 1982 Feb; 21(2):197-200. PubMed ID: 7063113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and evaluation of N-substituted nipecotic acid derivatives with an unsymmetrical bis-aromatic residue attached to a vinyl ether spacer as potential GABA uptake inhibitors.
    Quandt G; Höfner G; Wanner KT
    Bioorg Med Chem; 2013 Jun; 21(11):3363-78. PubMed ID: 23598250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of Non-GAT1-Selective Inhibitors: Challenges and Achievements.
    Damgaard M; Haugaard AS; Kickinger S; Al-Khawaja A; Lie MEK; Ecker GF; Clausen RP; Frølund B
    Adv Neurobiol; 2017; 16():315-332. PubMed ID: 28828618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluation of novel N-substituted nipecotic acid derivatives with a cis-alkene spacer as GABA uptake inhibitors.
    Tóth K; Höfner G; Wanner KT
    Bioorg Med Chem; 2019 Mar; 27(5):822-831. PubMed ID: 30718063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and pharmacological evaluation of new 4,4-diphenylbut-3-enyl derivatives of 4-hydroxybutanamides as GABA uptake inhibitors.
    Kowalczyk P; Höfner G; Wanner KT; Kulig K
    Acta Pol Pharm; 2012; 69(1):157-60. PubMed ID: 22574521
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.